• Bring Clarity to a Complex Disease
  • MultiOmyx - Hodgkin Lymphoma Profile
  • Advanced technologies to better characterize and assess cancer
GE Healthcare Biopharma Services

Pharma Services

GE Healthcare BioPharma Services provides expert product development support from discovery through product launch, including research services, biomarker discovery, assay development, clinical trial testing solutions, next generation sequencing, and data analytics.

Learn more 
PATHSiTE Virtual HemeFISH

PATHSiTE™ Virtual HemeFISH

Innovation Powered by Simplicity

PATHSiTE Virtual HemeFISH (VHF)  is the latest innovation in digital pathology services. VHF can help you better interpret, diagnose and report on suspected blood cancers and disorders.

Learn more 

MutiOmyx Logo
MutiOmyxMutiOmyxMutiOmyxMutiOmyxMutiOmyx

The first Hodgkin Lymphoma Profile on a single slide. MultiOmyx™… A multi-molecular, multiplexed, in-context tissue assessment platform to help dismantle secrets about cancer.

Learn more

Spotlight



Effective October 1, 2015, ICD-10 diagnosis codes must be used for all healthcare services provided in the U.S. Several resources available to you:
 Quick Start Guide  |  ICD-10 Basics  |  CMS Press Release  |   FAQ

All clinical laboratory services described in this website are provided by Clarient Diagnostic Services, Inc., a clinical laboratory licensed under the Clinical Laboratory Improvement Amendment of 1988 ("CLIA").
Clarient Diagnostic Services, Inc. is a wholly owned subsidiary of General Electric Company.